BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 700356)

  • 1. Actions of hallucinogens on ants (Formica pratensis)--I. Brain levels of LSD and the following oral administration.
    Frischknecht HR; Waser PG
    Gen Pharmacol; 1978; 9(5):369-73. PubMed ID: 700356
    [No Abstract]   [Full Text] [Related]  

  • 2. Actions of hallucinogens on ants (Formica pratensis)--II. Effects of amphetamine, LSD and delta-9-tetrahydrocannabinol.
    Frischknecht HR; Waser PG
    Gen Pharmacol; 1978; 9(5):375-80. PubMed ID: 700357
    [No Abstract]   [Full Text] [Related]  

  • 3. Actions of hallucinogens on ants (Formica pratensis)--III. Social behavior under the influence of LSD and tetrahydrocannabinol.
    Frischknecht HR; Waser PG
    Gen Pharmacol; 1980; 11(1):97-106. PubMed ID: 6245012
    [No Abstract]   [Full Text] [Related]  

  • 4. Characteristics of D-lysergic acid diethylamide binding to subcellular fractions derived from rat brain.
    Farrow JT; Van Vunakis H
    Biochem Pharmacol; 1973 May; 22(9):1103-13. PubMed ID: 4695669
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects.
    Dolder PC; Schmid Y; Steuer AE; Kraemer T; Rentsch KM; Hammann F; Liechti ME
    Clin Pharmacokinet; 2017 Oct; 56(10):1219-1230. PubMed ID: 28197931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of serotonin and LSD receptor binding following repeated administration of LSD.
    Trulson ME; Jacobs BL
    Life Sci; 1979 May; 24(22):2053-61. PubMed ID: 459700
    [No Abstract]   [Full Text] [Related]  

  • 7. Lysergic acid diethylamide (LSD 25). XXXX. Effect of pH on transport of methysergide and LSD 25 across gill membrane.
    Gettner HH; Carone PA; Abramson HA
    J Psychol; 1973 May; 84(1st Half):111-8. PubMed ID: 4705726
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics and subjective effects of 1P-LSD in humans after oral and intravenous administration.
    Grumann C; Henkel K; Brandt SD; Stratford A; Passie T; Auwärter V
    Drug Test Anal; 2020 Aug; 12(8):1144-1153. PubMed ID: 32415750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of [3H]LSD with serotonin receptors in human brain.
    Cross AJ
    Eur J Pharmacol; 1982 Aug; 82(1-2):77-80. PubMed ID: 7128680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of [3H]lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes.
    Geaney DP; Schächter M; Elliot JM; Grahame-Smith DG
    Eur J Pharmacol; 1984 Jan; 97(1-2):87-93. PubMed ID: 6698111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo 3H-d-LSD binding in small punched out rat brain regions.
    Kräuchi K; Feer H
    Experientia; 1980 Sep; 36(9):1094-5. PubMed ID: 7418848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of 3H-LSD binding sites in mouse brain in vivo.
    Duchemin AM; Quach TT; Rose C; Schwartz JC
    Life Sci; 1979 Jan; 24(5):401-9. PubMed ID: 431327
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolism of lysergic acid diethylamide (LSD) to 2-oxo-3-hydroxy LSD (O-H-LSD) in human liver microsomes and cryopreserved human hepatocytes.
    Klette KL; Anderson CJ; Poch GK; Nimrod AC; ElSohly MA
    J Anal Toxicol; 2000 Oct; 24(7):550-6. PubMed ID: 11043658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HISTOCHEMICAL STUDIES ON THE MECHANISM OF ACTION OF THE HALLUCINOGENS D-LYSERGIC ACID DIETHYLAMIDE TARTRATE (LSD-25) AND D-2-BROMO-LYSERGIC ACID TARTRATE (BOL-148) IN RAT BRAIN.
    SHANTHAVEERAPPA TR; NANDY K; BOURNE GH
    Acta Neuropathol; 1963 Sep; 3():29-39. PubMed ID: 14197655
    [No Abstract]   [Full Text] [Related]  

  • 15. Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain.
    Buckholtz NS; Zhou DF; Freedman DX; Potter WZ
    Neuropsychopharmacology; 1990 Apr; 3(2):137-48. PubMed ID: 1969270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The biochemical pharmacology of abused drugs. I. Amphetamines, cocaine, and LSD.
    Caldwell J; Sever PS
    Clin Pharmacol Ther; 1974 Oct; 16(4):625-38. PubMed ID: 4607666
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic usefulness of hallucinogenic drugs as a function of their chemical structure.
    Fischer R; Goldman H
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Jul; 8(4):176-84. PubMed ID: 1233520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and radioautography of [3H]LSD binding by rat brain slices in vitro: the effect of 5-hydroxytryptamine.
    Meibach RC; Maayani S; Green JP
    Eur J Pharmacol; 1980 Oct; 67(4):371-82. PubMed ID: 7449822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of [3H]lysergic acid diethylamide binding to mouse brain membranes by ethanol.
    Hirsch JD
    J Pharm Pharmacol; 1981 Jul; 33(7):475-7. PubMed ID: 6115041
    [No Abstract]   [Full Text] [Related]  

  • 20. Active transport of lysergic acid diethylamide.
    Wright EM
    Nature; 1972 Nov; 240(5375):53-4. PubMed ID: 4570642
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.